Urinary tract infections (UTIs) are one of the most common
bacterial infections seen in
primary care, second only to
infections of the
respiratory tract.
Women are particularly at
risk of developing UTIs because of their short
urethra, and certain behavioral factors which include delay in
micturition,
sexual activity and the use of
diaphragms and spermicides. Uncomplicated UTIs are usually treated empirically with
antibiotics. However, not everyone diagnosed with a UTI and treated with an
antibiotic will necessarily have a
bacterial infection. At least one-half of
women who suspect that they have UTI actually do. Studies have shown that one in 7
patients given an
antibiotic for UTI symptoms
will return within 28 days for a further
prescription of
antibiotic. Also, many UTIs are
self-limiting, improving without
treatment even when
culture is positive. Symptomatic
treatment of uncomplicated UTI may be an option which merits further
research.
Phenazopyridine is a
time-tested
urinary tract antiseptic and
analgesic that provide symptomatic relief of the
pain, burning, frequency and urgency associated with UTI.